Lithium Carbonate Capsule, Gelatin Coated
Product Images NDC 72789-173

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 72789-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

72789173 Label (72789173)

72789173 Label (72789173)
Each capsule of Lithium Carbonate Capsules USP contains 300mg of lithium carbonate USP. The normal adult dose is either 300mg or 600mg, to be taken three times a day. The packaging insert contains full prescribing information, and the capsules should be stored at a temperature of 20 to 25°C. They can be kept in excursions of 15 to 30°C. The capsules should be dispensed in a tightly closed child-resistant container, protected from moisture. The prescription drug should only be dispensed with a Medication Guide and kept out of the reach of children. The Lithium Carbonate Capsules USP are marketed and packaged by PD-Rx Pharmaceuticals, Inc. in Oklahoma City, OK, and manufactured by West-Ward Pharmaceuticals in Columbus, Ohio. GTIN: 00372789173016. SNO: B21D020002. EXP: 08/2022. LOT: B21D02.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.